Schonfeld Strategic Advisors LLC Gossamer Bio, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$15.4 Billion
Q4 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 154,700 shares of GOSS stock, worth $216,580. This represents 0.0% of its overall portfolio holdings.

Number of Shares

154,700

Previous 236,600 34.62%

Holding current value

$216,580

Previous $234,000 40.6%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.66 - $1.07 $54,054 - $87,633	-81,900 Reduced 34.62%	154,700 $139,000
Q3 2024 Nov 14, 2024	SELL	$0.79 - $1.25 $726,512 - $1.15 Million	-919,636 Reduced 79.54%	236,600 $234,000
Q2 2024 Aug 14, 2024	BUY	$0.51 - $1.27 $497,595 - $1.24 Million	975,678 Added 540.37%	1,156,236 $1.04 Million
Q1 2024 May 15, 2024	SELL	$0.8 - $1.51 $151,281 - $285,544	-189,102 Reduced 51.16%	180,558 $213,000
Q4 2023 Feb 14, 2024	BUY	$0.48 - $1.08 $4,684 - $10,540	9,760 Added 2.71%	369,660 $336,000
Q3 2023 Nov 14, 2023	SELL	$0.78 - $1.82 $19,890 - $46,410	-25,500 Reduced 6.62%	359,900 $298,000
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.53 $6,272 - $9,792	-6,400 Reduced 1.63%	385,400 $462,000
Q1 2023 May 15, 2023	SELL	$0.96 - $2.92 $491,232 - $1.49 Million	-511,700 Reduced 56.64%	391,800 $493,000
Q4 2022 Feb 14, 2023	BUY	$1.74 - $12.87 $1.35 Million - $9.96 Million	774,156 Added 598.52%	903,500 $1.96 Million
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $660,205 - $1.36 Million	91,568 Added 242.4%	129,344 $1.55 Million
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $345,209 - $576,505	-57,824 Reduced 60.49%	37,776 $315,000
Q1 2022 May 16, 2022	SELL	$8.44 - $12.49 $227,036 - $335,981	-26,900 Reduced 21.96%	95,600 $830,000
Q4 2021 Feb 14, 2022	BUY	$10.12 - $14.07 $224,663 - $312,354	22,200 Added 22.13%	122,500 $1.39 Million
Q3 2021 Nov 16, 2021	BUY	$7.25 - $13.23 $727,175 - $1.33 Million	100,300 New	100,300 $1.26 Million
Q2 2021 Aug 16, 2021	SELL	$8.0 - $9.75 $399,216 - $486,544	-49,902 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.63 - $10.94 $52,297 - $66,296	6,060 Added 13.82%	49,902 $461,000
Q4 2020 Feb 16, 2021	BUY	$8.3 - $13.59 $363,888 - $595,812	43,842 New	43,842 $423,000

Others Institutions Holding GOSS

# of Institutions

116

Shares Held

163M

Call Options Held

821K

Put Options Held

557K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $132M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Gossamer Bio, Inc. Transaction History